NOTCH1 and leukemia: In contrast, the SERCA inhibitor CAD204520 demonstrates reduced Ca2+-related toxicity and yet retrains its anti-NOTCH1 effect, which made it an ideal compound for assessing the relevance of NOTCH1 in MLLr leukemia in this study [26].